Beranda › Limfoma Sel B Besar Difus › Maryland › Baltimore
Uji klinis Limfoma Sel B Besar Difus di Baltimore, MD
5 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Menerima pesertaFase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Menerima pesertaFase 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Menerima pesertaStudi observasional
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
DALY II USA/ MB-CART2019.1 for DLBCL
Menerima pesertaFase 2
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Menerima pesertaFase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Uji klinis Limfoma Sel B Besar Difus di kota lain
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Houston, TX17 studi
- Los Angeles, CA17 studi
- Boston, MA16 studi
- Milwaukee, WI16 studi
- Nashville, TN15 studi
- Portland, OR15 studi
- Philadelphia, PA15 studi
- Durham, NC14 studi
- Dallas, TX13 studi
Studi lain di Baltimore
- Kanker Paru Non-Sel Kecil60 studi
- Kanker Payudara47 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Kanker (semua jenis)37 studi
- Kanker Kolorektal31 studi
- Kanker Pankreas31 studi
- Kanker Metastatik28 studi
- Obesitas25 studi
- Gagal Jantung24 studi
- Kanker Kandung Kemih24 studi
- Stroke22 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.